To assess whether SYK and PI3K inhibitors can counteract macrophage hyperactivation by serum-derived immune complexes, we generated spike–IgG immune complexes by incubating the spike protein with sera obtained from severely ill COVID-19 patients hospitalized at Amsterdam UMC from the first wave in early 2020. This evidence concerns the gene SYK and COVID-19.